An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors

Pediatric Blood and Cancer

Volumn 47, Issue 1, 2006, Pages 83-88

  Peterson, Katia M ^a,b   Shao, Cheng ^a   McCarter, Robert ^a   MacDonald, Tobey J ^a   Byrne, Julianne ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b Office of Medical Services DC   (United States)

Author keywords

Childhood brain tumors; Late effects; Secondary malignant neoplasm (SMN); Surveillance, epidemiology and end results (SEER)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN CANCER; BRAIN TUMOR; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; INFANT; LONG TERM CARE; MALE; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVORS; UNITED STATES;

EID: 33646868861     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20690     Document Type: Article

References (28)

1. Bondy ML, Lustbader ED, et al. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991;8:253-267.
2. Biegel JA. Genetics of pediatric central nervous system tumors. J Pediatr Hematol Oncol 1997;19:492-501.
3. Heideman R, Packer RJ, Albright L, et al. Tumors of the central nervous system. In: Phillip Pizzo DPM, editor. Principles and practices of pediatric oncology. Philadelphia: Lippincott-Raven; 1997. pp 633-698.
4. Meadows AT, Fenton J. Follow-up care of patients at risk for the development of second malignant neoplasms. In: Schwartz C, Hobbie W, Constine L, Ruccione K, editors. Survivors of childhood cancer. St. Louis: Mosby; 1994. pp 319-327.
5. Stiller CA, Nectoux J. International incidence of childhood brain and spinal tumours. Int J Epidemiol 1994;23:458-464.
6. Heideman RL, Douglass EC, et al. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: A Pediatric Oncology Group Study. J Neurooncol 1995;25:77-84.
7. Davis FG, Freels S, et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88:1-10.
8. Duffner PK, Krischer JP, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A Pediatric Oncology Group study. Ann Neurol 1998;44:313-316.
9. Mertens AC, Yasui Y, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163-3172.
10. Neglia JP, Friedman DL, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-629.
11. Davis FG, McCarthy BJ, et al. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro-oncol 1999;1:205-211.
12. NCI. Surveillance, Epidemiology, and End Results Program Public-Use Data(SEER) 1973-1998. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch 2001.
13. SAS. SAS. Cary, NC: SAS Institute; 2001.
14. StataCorp. Stata Statistical Software. College Sation, TX: Stata Corporation 2003.
15. SEER. SEER public use database. National Cancer Institute 2003.
16. Goldstein AM, Yuen J, et al. Second cancers after medulloblastoma: Population-based results from the United States and Sweden. Cancer Causes Control 1997;8:865-871.
17. Salminen E, Pukkala E, et al. Second cancers in patients with brain tumours-Impact of treatment. Eur J Cancer 1999;35:102-105.
18. Inskip PD. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer. Cancer 2003;98:562-570.
19. Minn AY, Pollock BH, et al. Surveillance neuroimaging to detect relapse in childhood brain tumors: A Pediatric Oncology Group study. J Clin Oncol 2001;19:4135-4140.
20. Castello MA, Clerico A, et al. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol 1990;12:297-300.
21. Finlay JL, August C, et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neurooncol 1990;9:239-248.
22. Abrahamsen TG, Lange BJ, et al. A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors. J Pediatr Hematol Oncol 1995;17:134-139.
23. Lyden DC, Mason WP, et al. The expanding role of chemotherapy for pediatric supratentorial malignant gliomas. J Neurooncol 1996;28:185-191.
24. Reddy AT, Packer RJ. Chemotherapy for low-grade gliomas. Childs Nerv Syst 1991;15:506-513.
25. Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurol Clin 2003;21:897-913.
26. Le Deley MC. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr Blood Cancer 2005;45:25-31.
27. Finlay JL, Goins SC. Brain tumors in children. III. Advances in chemotherapy. Am J Pediatr Hematol Oncol 1987;9:264-271.
28. Garwicz S, Anderson H, et al. Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 2000;88:672-678.